Are there any laws governing the use of prescription drug monitoring programs to obtain prescription drugs?

In Pennsylvania, laws governing the use of prescription drug monitoring programs (PDMPs) to obtain prescription drugs are set out in the Pennsylvania Prescription Drug Monitoring Program Act. The PDMP Act requires that prescribers and dispensers report certain controlled substances to the program. Additionally, it includes provisions that limit individuals to one prescriber and one pharmacy to obtain the same Schedule II, III, or IV controlled substance, and requires authorized users of the PDMP, such as prescribers and dispensers, to review the PDMP data prior to prescribing or dispensing a controlled substance. The PDMP is designed to help prescribers and pharmacists identify when an individual may be at risk of abuse or misuse of the drugs, as well as help them track the sale and distribution of controlled substances. The Pennsylvania Prescription Drug Monitoring Program Act also provides protection for prescribers and pharmacists who use the PDMP. It sets criminal penalties for individuals who fraudulently obtain prescription drugs, and requires that PDMP data be confidential and not accessible to the general public. The PDMP also includes provisions for setting up a process for auditing and monitoring the use of PDMP data. The PDMP also works with law enforcement in Pennsylvania to help investigate and prosecute individuals who are suspected of illegally obtaining prescription drugs. These PDMP laws are in place to help protect both prescribers and patients from addiction and abuse of prescription drugs. They are also an important tool to help combat the opioid crisis and reduce the number of opioid-related deaths in Pennsylvania.

Are there any laws governing the use of prescription drug monitoring programs to obtain prescription drugs?

Related FAQs

Related Blog Posts